Doreen Moraa Muracha is a top HIV activist in Kenya. Doreen is also a top You Tube Content Creator who loves to tell people on latest upcoming trends and stories about HIV. Doreen loves to update her fans about new trials of modern ARV injectables and other HIV related updates. Doreen also teaches her fans how to live HIV free and how to live as undetectable queens and kings by adhering to their HIV regimen.
Doreen has posted a tbt photo that reminds her of a time that she and her mum went to visit the famous Loliondo Witch doctor, who claimed to cure HIV. Doreen and her mum were given a concortion to drink which was worth one hundred shillings. Upon drinking, Doreen and her mum were told to stop their ARv treatment and that they were fully healed.
However, after Doreen stopped her treatment for two years, her health deteriorated and on visiting the Hospital, she and her mum had to be put on ARV regimen again. See Doreen's post below.
Content created and supplied by: Ravera (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More